Northern Trust Corp Omega Therapeutics, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 164,774 shares of OMGA stock, worth $201,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares

164,774

Previous 199,741 17.51%

Holding current value

$201,024

Previous $729,000 53.22%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.86 - $3.2 $65,038 - $111,894	-34,967 Reduced 17.51%	164,774 $341,000
Q1 2024 May 14, 2024	BUY	$2.73 - $5.32 $6,527 - $12,720	2,391 Added 1.21%	199,741 $729,000
Q4 2023 Feb 13, 2024	SELL	$1.35 - $3.21 $5,184 - $12,326	-3,840 Reduced 1.91%	197,350 $594,000
Q3 2023 Nov 13, 2023	SELL	$2.15 - $5.68 $6,710 - $17,727	-3,121 Reduced 1.53%	201,190 $432,000
Q2 2023 Aug 11, 2023	BUY	$5.6 - $9.66 $923,658 - $1.59 Million	164,939 Added 418.92%	204,311 $1.14 Million
Q1 2023 May 15, 2023	BUY	$4.81 - $10.95 $11,649 - $26,520	2,422 Added 6.55%	39,372 $237,000
Q4 2022 Feb 13, 2023	BUY	$4.22 - $7.05 $41,212 - $68,850	9,766 Added 35.93%	36,950 $210,000
Q3 2022 Nov 14, 2022	BUY	$3.63 - $6.65 $26,502 - $48,551	7,301 Added 36.72%	27,184 $147,000
Q2 2022 Aug 12, 2022	SELL	$2.01 - $7.19 $299,705 - $1.07 Million	-149,107 Reduced 88.23%	19,883 $76,000
Q1 2022 May 13, 2022	BUY	$6.24 - $14.04 $600,263 - $1.35 Million	96,196 Added 132.15%	168,990 $1.06 Million
Q4 2021 Feb 08, 2022	BUY	$11.33 - $29.38 $71,390 - $185,123	6,301 Added 9.48%	72,794 $825,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $22.51 $1.06 Million - $1.5 Million	66,493 New	66,493 $1.25 Million

Others Institutions Holding OMGA

# of Institutions

Shares Held

45.3M

Call Options Held

36.9K

Put Options Held

33.5K

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $58.4M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Omega Therapeutics, Inc. Transaction History